CRM reported Q2 results on August 26 with the bears already largely gone, leaving the post-print debate squarely in the hands of bulls and a cautious analyst middle ground.
Short interest has continued its retreat since the August 23 preview note. Positions fell another 11% in a single session on August 25, bringing the SI to 2.99% of the free float — down from roughly 4.4% a month ago. The borrow market reflects the same reality: availability is effectively bottomless at nearly 3,900% of short interest, with over 510 million shares available to lend against fewer than 29 million shorted. Cost to borrow has eased to 0.36%, down more than 20% on the week. Options positioning has edged slightly more defensive — the put/call ratio moved to 0.87, about 1.2 standard deviations above its 20-day average, and briefly touched its 52-week high of 0.91 the prior session. That's a mild hedge signal, but with the ratio near the top of its annual range rather than screaming distress, the overall read is cautious rather than panicked. Positioning ahead of this print was as loose as it has been in months.
The analyst community has been busy this week, and the picture is genuinely split. Multiple firms reiterated buy-side ratings with targets ranging from $225 to $315 — Citizens and BTIG both held firm at the upper end — but the sceptics are clustered right around the current price. Citigroup raised its Neutral target to $204 earlier this month; UBS lifted its Neutral target to $210; Wells Fargo, also sitting on the sidelines at Equal-Weight, raised to $205. Those three targets sit within a few dollars of the $205.69 close, implying the fence-sitters see almost no upside from here. The consensus mean target of $243 looks constructive on paper, but it is being pulled up by the high-conviction bulls while the neutral camp has effectively marked the stock fair value. The bear case — weaker organic bookings, aggressive pricing concerns, AI product uncertainty — is not a fringe view on the Street right now.
On valuation, the trailing P/E has expanded about 14% over the past 30 days as the stock rallied, closing near 13x. EV/EBITDA has been relatively stable. The dividend score ranks in the 96th percentile of the universe, an unusual distinction for a growth-oriented software name, though it reflects the disciplined capital return programme rather than yield-seeking. The ORTEX short score has drifted lower over the past two weeks to 33.9, consistent with the continued short covering — the lending market simply does not flag any squeeze tension here. Peers moved broadly in step on the day: NOW fell 0.8%, ADBE dropped 0.9%, and GWRE slid nearly 2%, suggesting the sector-wide tone on August 25 was soft rather than anything Salesforce-specific.
The post-earnings reaction history offers some framing. The May 28 print produced a 7.7% one-day gain and held 6.3% through five days. The prior quarter moved the other way, slipping 1.6% on the day before recovering to a 6.4% five-day gain. Both episodes saw positive five-day drift regardless of the initial move. With shorts largely covered and borrow conditions loose, there is no structural forced-buying dynamic to amplify a beat — nor is there a crowded short position to squeeze. The reaction will be driven by what management says about AI monetisation and whether the organic bookings picture has stabilised, the two issues the bear camp has flagged most persistently.
What to watch: the degree to which guidance language on AI-driven revenue and cRPO growth either closes the gap between the neutral camp's near-current-price targets and the bull camp's $250-plus range — or widens it further.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
